Binghamton University chemists have discovered a new mechanism that could potentially lead to quicker outcomes in pharmaceutical research.  Carbon-halogen bonds...

Revolver Therapeutics, a University of Bath spin-out building a new class of drug discovery tools, has won the Health category...

Viral Science News A new phase I clinical study has mapped how two widely discussed drugs—ticagrelor and fazamorexant—may interact in...

Insilico Medicine founders Dr. Alex Zhavoronkov and Dr. Feng Ren have been invited to the inaugural China Pioneer Innovative Drug...

TUCSON, Ariz., July 16, 2026 — Critical Path Institute’s® (C-Path) New Approach Methodologies Developer Coalition (NAMs-DC) has added Crown Bioscience...

Glioblastoma remains one of the deadliest brain cancers, notorious for its resistance to standard therapy and its ability to adapt...

Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global...

In a groundbreaking advancement for targeted drug delivery, an international team of scientists has successfully combined asymmetric-flow field-flow fractionation (AF4)...

A groundbreaking meta-analysis has emerged, shedding unprecedented light on the pharmacological strategies employed to combat muscular degeneration in Duchenne muscular...

In the relentless pursuit of new therapeutics, structure-based virtual screening (VS) through molecular docking has cemented its role as a...